Hypervirulent Klebsiella pneumoniae: Insights into Virulence, Antibiotic Resistance, and Fight Strategies Against a Superbug
Pharmaceuticals · 15.05.2025 · 18 (5) · 724
DOI: 10.3390/ph18050724 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 15.05.2025. Verfasst von Helal F Hetta und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Microbiology, Immunology and Biotechnology, Department of Natural Products and Alternative Medicine, Faculty of Pharmacy, University of T…. Die Arbeit wurde bisher 60-mal zitiert (Crossref) und nennt 184 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Community-acquired infections caused by Klebsiella pneumoniae (K. pneumoniae) have become a significant global health concern, particularly with the emergence of hypervirulent strains (hvKP). These strains are associated with severe infections, such as pyogenic liver abscesses, even in otherwise healthy individuals. Initially reported in Taiwan in the 1980s, hvKP has now spread worldwide. The pathogenicity of hvKP is attributed to an array of virulence factors that enhance its ability to colonize and evade host immune defenses. Additionally, the convergence of hypervirulence with antibiotic resistance has further complicated treatment strategies. As a member of the ESKAPE group of pathogens, K. pneumoniae exhibits high resistance to multiple antibiotics, posing a challenge for healthcare settings. This review provides a comprehensive overview of hvKP, highlighting its structural and pathogenic differences from classical K. pneumoniae strains, key virulence factors, mechanisms of antibiotic resistance, and the increasing threat of multidrug-resistant hvKP. Lastly, we discuss current treatment guidelines and emerging therapeutic strategies to combat this formidable pathogen.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Microbiology, Immunology and Biotechnology, Department of Natural Products and Alternative Medicine, Faculty of Pharmacy, University of Tabuk, Tabuk 71491, Saudi Arabia.
- Department of Pharmacology and Toxicology, Faculty of Pharmacy, University of Tabuk, Tabuk 71491, Saudi Arabia.
- Department of Pharmacy Practice, Faculty of Pharmacy, University of Tabuk, Tabuk 71491, Saudi Arabia.
- Department of Clinical Pharmacy, College of Pharmacy, Jouf University, Sakaka 72388, Saudi Arabia.
- Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taibah University, Madina 41477, Saudi Arabia.
- Department of Pathology and Laboratory Medicine, College of Medicine, University of Cincinnati, Cincinnati, OH 45221, USA.
ORCID-Profile: Helal F Hetta, Mostafa A Sayed Ali, Ahmed D Alatawi, Hashim M Aljohani, Rehab Ahmed, Yasmin N Ramadan
Zitieren
APA
Hetta, H. F., Alanazi, F. E., Ali, M. A. S., Alatawi, A. D., Aljohani, H. M., Ahmed, R., Alansari, N. A., Alkhathami, F. M., Albogmi, A., Alharbi, B. M., Alanzi, H. S., Alaqyli, A. B., & Ramadan, Y. N. (2025). Hypervirulent Klebsiella pneumoniae: Insights into Virulence, Antibiotic Resistance, and Fight Strategies Against a Superbug. Pharmaceuticals, 18(5), 724. https://doi.org/10.3390/ph18050724
Vancouver
Hetta HF, Alanazi FE, Ali MAS, Alatawi AD, Aljohani HM, Ahmed R, et al. Hypervirulent Klebsiella pneumoniae: Insights into Virulence, Antibiotic Resistance, and Fight Strategies Against a Superbug. Pharmaceuticals. 2025;18(5):724. doi:10.3390/ph18050724
BibTeX
@article{Hetta2025,
author = {Hetta, Helal F and Alanazi, Fawaz E and Ali, Mostafa A Sayed and Alatawi, Ahmed D and Aljohani, Hashim M and Ahmed, Rehab and Alansari, Nuha A and Alkhathami, Fahad M and Albogmi, Alaa and Alharbi, Bander M and Alanzi, Hanadi S and Alaqyli, Amirah B and Ramadan, Yasmin N},
title = {Hypervirulent Klebsiella pneumoniae: Insights into Virulence, Antibiotic Resistance, and Fight Strategies Against a Superbug},
journal = {Pharmaceuticals},
year = {2025},
volume = {18},
number = {5},
pages = {724},
doi = {10.3390/ph18050724}
}
EUVIMED